SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
COCP

Cocrystal Pharma, Inc. (NASDAQ:COCP)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.97+0.02 (+2.31%)
 
Market cap
$18.7M
Insider Score
Analyst consensus
Listed since
Feb 22, 2012
Insider Score
/ 100
COCP Insider Score

Cocrystal Pharma, Inc. has a live Insider Score.

Scored on 2 qualifying trades from 1 insider in the last 90 days.

Unlock the score

COCP Income Statement

Fiscal PeriodQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025
Revenue105.00 K225.00 K0.000.000.000.00
Revenue Growth (YoY)——————
Cost of Revenue0.000.000.000.000.000.00
Gross Profit105.00 K225.00 K0.000.000.000.00
SG&A Expense1.15 M1.21 M862.00 K1.14 M986.00 K981.00 K
R&D Expense2.14 M1.37 M1.62 M954.00 K1.12 M1.36 M
Operating Expenses3.29 M2.58 M2.48 M2.09 M2.11 M2.34 M
Operating Income-3.18 M-2.36 M-2.48 M-2.09 M-2.11 M-2.34 M
Pretax Income-3.16 M-2.30 M-2.43 M-2.05 M-2.06 M-2.30 M
Tax Provision0.000.000.000.000.000.00
Net Income-3.16 M-2.30 M-2.43 M-2.05 M-2.06 M-2.30 M
EPS (Basic)-0.23-0.17-0.21-0.19-0.20-0.23
EPS (Diluted)-0.23-0.17-0.21-0.19-0.20-0.23
Shares Outstanding13.79 M13.79 M11.29 M10.99 M10.17 M10.17 M

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.